162 related articles for article (PubMed ID: 22777997)
1. Bevacizumab in lung cancer: lackluster performance and unjustified expense?
Dasanu CA
J Oncol Pharm Pract; 2012 Sep; 18(3):381-2. PubMed ID: 22777997
[TBL] [Abstract][Full Text] [Related]
2. The use of bevacizumab in non-small cell lung cancer: an update.
Lauro S; Onesti CE; Righini R; Marchetti P
Anticancer Res; 2014 Apr; 34(4):1537-45. PubMed ID: 24692680
[TBL] [Abstract][Full Text] [Related]
3. Optimizing the dose and schedule of anti-vascular endothelial growth factor antibodies in non-small-cell lung cancer.
Klamerus JF; Brahmer JR
Clin Lung Cancer; 2008 Mar; 9 Suppl 2():S51-6. PubMed ID: 21884999
[TBL] [Abstract][Full Text] [Related]
4. [Antiangiogenic agents: current limits in thoracic oncology].
Dansin E; Lauridant G; Chahine B
Bull Cancer; 2012 Nov; 99(11):1083-91. PubMed ID: 23113985
[TBL] [Abstract][Full Text] [Related]
5. MO19390 (SAiL): bleeding events in a phase IV study of first-line bevacizumab with chemotherapy in patients with advanced non-squamous NSCLC.
Dansin E; Cinieri S; Garrido P; Griesinger F; Isla D; Koehler M; Kohlhaeufl M
Lung Cancer; 2012 Jun; 76(3):373-9. PubMed ID: 22236866
[TBL] [Abstract][Full Text] [Related]
6. Bevacizumab in non-small cell lung cancer: an overview of practice in the era of molecular testing.
Snee M
Clin Oncol (R Coll Radiol); 2014 Aug; 26(8):468-72. PubMed ID: 24909702
[TBL] [Abstract][Full Text] [Related]
7. Phase 2 trial of maintenance bevacizumab alone after bevacizumab plus pemetrexed and carboplatin in advanced, nonsquamous nonsmall cell lung cancer.
Stevenson JP; Langer CJ; Somer RA; Evans TL; Rajagopalan K; Krieger K; Jacobs-Small M; Dyanick N; Milcarek B; Coakley S; Walker S; Eaby-Sandy B; Hageboutros A
Cancer; 2012 Nov; 118(22):5580-7. PubMed ID: 22544579
[TBL] [Abstract][Full Text] [Related]
8. Bevacizumab in non-small-cell lung cancer: a review.
Planchard D
Expert Rev Anticancer Ther; 2011 Aug; 11(8):1163-79. PubMed ID: 21916570
[TBL] [Abstract][Full Text] [Related]
9. Bevacizumab as adjuvant therapy for lung cancer does not help patients over 65.
Roehr B
BMJ; 2012 Apr; 344():e2855. PubMed ID: 22517975
[No Abstract] [Full Text] [Related]
10. Evaluating the impact of bevacizumab maintenance therapy on overall survival in advanced non-small-cell lung cancer.
Dranitsaris G; Beegle N; Ravelo A; Kalberer T; Yu E; Thomas S
Clin Lung Cancer; 2013 Mar; 14(2):120-7. PubMed ID: 22868222
[TBL] [Abstract][Full Text] [Related]
11. A trial-based assessment of the cost-utility of bevacizumab and chemotherapy versus chemotherapy alone for advanced non-small cell lung cancer.
Goulart B; Ramsey S
Value Health; 2011; 14(6):836-45. PubMed ID: 21914503
[TBL] [Abstract][Full Text] [Related]
12. Osteonecrosis of the jaw in a patient with advanced non-small-cell lung cancer receiving bevacizumab.
Katsenos S; Christophylakis C; Psathakis K
Arch Bronconeumol; 2012 Jun; 48(6):218-9. PubMed ID: 22429334
[No Abstract] [Full Text] [Related]
13. Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancer.
Spigel DR; Anthony Greco F; Waterhouse DM; Shipley DL; Zubkus JD; Bury MJ; Webb CD; Hart LL; Gian VG; Infante JR; Burris HA; Hainsworth JD
Lung Cancer; 2012 Oct; 78(1):70-5. PubMed ID: 22947511
[TBL] [Abstract][Full Text] [Related]
14. Bevacizumab in lung cancer: hurdles in clinical development.
Pirker R
Lancet Oncol; 2010 Aug; 11(8):703-4. PubMed ID: 20650687
[No Abstract] [Full Text] [Related]
15. Bevacizumab in the treatment of advanced, non-squamous non-small cell lung cancer: an evidence-based approach.
Tassinari D; Sartori S; Papi M; Drudi F; Castellani C; Carloni F; Tombesi P; Lazzari-Agli L
Oncology; 2011; 80(5-6):350-8. PubMed ID: 21791945
[TBL] [Abstract][Full Text] [Related]
16. [Anti-VEGF therapy for lung cancer].
Taira T; Yamamoto N
Nihon Rinsho; 2012 Dec; 70(12):2159-64. PubMed ID: 23259390
[TBL] [Abstract][Full Text] [Related]
17. Complete regression of a non-small cell lung cancer choroidal metastasis with intravitreal bevacizumab.
D'Antonio C; Viterbo A; Romiti A; Enrici MM; Lauro S; Marchetti P
J Thorac Oncol; 2012 Feb; 7(2):468-9. PubMed ID: 22252564
[No Abstract] [Full Text] [Related]
18. Current treatments for advanced stage non-small cell lung cancer.
Stinchcombe TE; Socinski MA
Proc Am Thorac Soc; 2009 Apr; 6(2):233-41. PubMed ID: 19349493
[TBL] [Abstract][Full Text] [Related]
19. [Bevacizumab in the treatment of non-small cell lung cancer].
Knuuttila A; Rouhos A; Karjalainen EM; Riska H; Pietiläinen M; Paunu N; Salomaa ER
Duodecim; 2009; 125(4):361-8. PubMed ID: 19358416
[TBL] [Abstract][Full Text] [Related]
20. Selection of chemotherapy for patients with advanced non-small cell lung cancer.
Pennell NA
Cleve Clin J Med; 2012 May; 79 Electronic Suppl 1():eS46-50. PubMed ID: 22614966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
